Abbott Laboratories (NYSE: ABT) is entering into an agreement with Action Pharma A/S to develop and commercialize Action’s AP214, a compound to prevent acute kidney injury associated with major cardiac surgery. Under terms of the deal, ABT will pay Action, a company...
Brought to you by www.DealSearchOnline.com July 2, 2012 Issue: Recent Health Care M&A Deals The Premiums They Paid, Part II – Biotechnology Premiums For The Past Five Years Spotlight on: Medical Devices Conference Calendar Recent Health Care...
FOR IMMEDIATE RELEASE Stephen M. Monroe, Partner Sanford B. Steever, Editor 800-248-1668 203-846-6800 Fax: 203-846-8300 pressreleases@levinassociates.com NORWALK, CT – October 17, 2011 – In the health care industry, the third quarter dollar volume contributed $58.9...
Life sciences company Agilent Technologies (NYSE: A) recently acquired Dako Denmark A/S, a leader in tissue-based cancer diagnostics, from the private equity fund EQT. Dako’s products are supplied to anatomic pathology labs and generate annual revenue of $326.6...
In the only Hospital deal to come with a price in May, MultiCare Health System, a four-hospital integrated delivery system based in Tacoma, Washington, is acquiring Auburn Regional Medical Center, a 213-bed hospital in Auburn, Washington. The seller is Universal...
In May’s largest Pharmaceutical transaction, Novartis AG (NYSE: NVS) is buying Fougera Pharmaceuticals, a company based in Melville, New York that manufactures generic skin care medicine, such as drugs for acne, eczema and rosacea. In 2011, Fougera generated revenue...